| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/28/2002 | WO2002016598A2 Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | WO2002016595A2 Kidney-specific protein |
| 02/28/2002 | WO2002016593A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2002 | WO2002016591A2 Human transporter family members and uses thereof |
| 02/28/2002 | WO2002016590A2 Methods and compositions for increasing protein yield from a cell culture |
| 02/28/2002 | WO2002016589A2 Human abc transporter family member and uses thereof |
| 02/28/2002 | WO2002016587A2 Microtubule-associated proteins and tubulins |
| 02/28/2002 | WO2002016585A2 Imidazoline receptor homologs |
| 02/28/2002 | WO2002016584A2 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | WO2002016582A2 Human sodium-sugar symporter family member and uses thereof |
| 02/28/2002 | WO2002016579A2 Nucleic acids, vectors, host cells, polypeptides and uses thereof |
| 02/28/2002 | WO2002016578A2 Secreted proteins and methods of using same |
| 02/28/2002 | WO2002016576A1 11 human secreted proteins |
| 02/28/2002 | WO2002016573A2 Genetically modified, non-human mammal containing an additional inducible regulator gene |
| 02/28/2002 | WO2002016561A2 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | WO2002016558A1 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
| 02/28/2002 | WO2002016553A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 02/28/2002 | WO2002016551A2 Trance regulation of chondrocyte differentiation |
| 02/28/2002 | WO2002016549A2 METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE |
| 02/28/2002 | WO2002016439A2 Novel nucleic acids and polypeptides |
| 02/28/2002 | WO2002016435A2 Human 7tm proteins and polynucleotides encoding the same |
| 02/28/2002 | WO2002016434A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION |
| 02/28/2002 | WO2002016433A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016432A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016431A2 PEPTIDES OF THE α1-ADRENERGIC RECEPTOR AND THEIR USE FOR PSORIASIS |
| 02/28/2002 | WO2002016430A2 Peptide with effects on cerebral health |
| 02/28/2002 | WO2002016429A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016428A1 Irap-binding protein |
| 02/28/2002 | WO2002016427A1 Crystal structure of a ras-pi3k complex |
| 02/28/2002 | WO2002016426A2 Coaster, a human coactivator of steroid receptors |
| 02/28/2002 | WO2002016425A1 Protein of phenoloxidase system and gene coding the same |
| 02/28/2002 | WO2002016424A2 Dna binding peptide domains and a method for providing domains of this type |
| 02/28/2002 | WO2002016423A2 PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+/H+ ANTIPORTERS |
| 02/28/2002 | WO2002016422A2 Recombinant constructs of borrelia burgdorferi |
| 02/28/2002 | WO2002016421A2 Altered ospa of borrelia burgdorferi |
| 02/28/2002 | WO2002016420A2 Antiviral compounds derived from the hsv gd protein and methods |
| 02/28/2002 | WO2002016419A2 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | WO2002016418A2 An iap binding peptide or polypeptide and methods of using the same |
| 02/28/2002 | WO2002016417A2 Transgenic animal model for neurodegerative disease and uses thereof |
| 02/28/2002 | WO2002016416A2 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016414A2 Composition for the elimination of autoreactive b-cells |
| 02/28/2002 | WO2002016413A2 Cripto tumour polypeptide |
| 02/28/2002 | WO2002016412A2 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 02/28/2002 | WO2002016411A2 Binding polypeptides and methods based thereon |
| 02/28/2002 | WO2002016410A2 Peptide selection method |
| 02/28/2002 | WO2002016402A2 Apoptotic compounds |
| 02/28/2002 | WO2002016400A2 Haplotypes of the scya26 gene |
| 02/28/2002 | WO2002016399A2 Haplotypes of the tacr1 gene |
| 02/28/2002 | WO2002016396A2 Mammalian rh type b glycoprotein ion transporter |
| 02/28/2002 | WO2002016390A1 21 human secreted proteins |
| 02/28/2002 | WO2002016389A1 23 human secreted proteins |
| 02/28/2002 | WO2002016388A1 21 human secreted proteins |
| 02/28/2002 | WO2002016387A1 12 human secreted proteins |
| 02/28/2002 | WO2002016385A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | WO2002015941A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 02/28/2002 | WO2002015939A2 Calycins |
| 02/28/2002 | WO2002015928A1 METHOD OF ADMINISTERING FimH PROTEIN AS A VACCINE FOR URINARY TRACT INFECTIONS |
| 02/28/2002 | WO2002015925A1 Methof of regulating apoptosis and apoptosis-regulatory polypeptide |
| 02/28/2002 | WO2002015924A1 Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer |
| 02/28/2002 | WO2002015923A1 Orally administered peptides to ameliorate atherosclerosis |
| 02/28/2002 | WO2002015701A2 Bacillus thuringiensis crystal protein hybrids |
| 02/28/2002 | WO2002015681A1 Transgenic mammals |
| 02/28/2002 | WO2002015680A1 Type iii allergic inflammation model animal |
| 02/28/2002 | WO2002015675A1 Genes for modifying plant traits iv |
| 02/28/2002 | WO2002015674A1 Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
| 02/28/2002 | WO2002015661A2 Inhibitors of hiv replication and method of treatment of hiv infections |
| 02/28/2002 | WO2002002631A8 Structure-based drug design method to identify compounds that bind to cd81, a cell receptor for hepatitis-c |
| 02/28/2002 | WO2002002586A8 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same |
| 02/28/2002 | WO2001094532A3 A novel polypeptide, ribosomal protein l39 9 and the polynucleotide encoding the polypeptide |
| 02/28/2002 | WO2001085967A3 Corynebacterium glutamicum strain with enhanced secretion activity |
| 02/28/2002 | WO2001085903A3 A novel polypeptide- human protein 9 which contains a p5cr characteristic sequence fragment and a polynucleotide encoding the same |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085196A3 Cxcr4 antagonist treatment of hematopoietic cells |
| 02/28/2002 | WO2001083747A3 Prion proteins and their uses |
| 02/28/2002 | WO2001081609A3 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/28/2002 | WO2001081380A3 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/28/2002 | WO2001081361A8 Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death |
| 02/28/2002 | WO2001079446A3 Materials and methods relating to lipid metabolism |
| 02/28/2002 | WO2001079438A3 A new polypeptide- human amyloid precursor protein-binding protein 9 and the polynucleotide encoding it |
| 02/28/2002 | WO2001079437A3 Novel polypeptide a human cell differential transcriptional factor 14 and polynucleotide encoding it |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079225A3 Haplotypes of the csf1r gene |
| 02/28/2002 | WO2001079216A3 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 02/28/2002 | WO2001079144A3 Fyn kinase as a target for modulation of integrin mediated signal transduction |
| 02/28/2002 | WO2001078796A9 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 02/28/2002 | WO2001078767A3 Pharmaceutical preparations comprising modified peptides |
| 02/28/2002 | WO2001077377A8 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 02/28/2002 | WO2001077334A3 Lactococcus lactis genome, polypeptides and uses |
| 02/28/2002 | WO2001077292A3 Novel signal transduction molecules |
| 02/28/2002 | WO2001077125A3 Haplotypes of the ccr5 gene |
| 02/28/2002 | WO2001076636A3 Pharmaceutical composition of modified pna molecules |
| 02/28/2002 | WO2001076615A3 Cxcr4 agonist treatment of hematopoietic cells |
| 02/28/2002 | WO2001075112A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/28/2002 | WO2001075064A3 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 02/28/2002 | WO2001075053A3 A novel polypeptide, human chaperonine 14 and the polynucleotide encoding the polypeptide |
| 02/28/2002 | WO2001073083A3 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
| 02/28/2002 | WO2001073029A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |